The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

ACCELERATE multi-stakeholder paediatric platform

The ACCELERATE platform, ‘Innovation for Children with Cancer’, was created in December 2013 jointly by the Cancer Drug Development Forum (CDDF), the European Consortium for Innovative Therapies for Children with Cancer (ITCC), and the European Society of Paediatric Oncology (SIOPE) within the project of the European Network for Cancer Research (ENCCA), with the mission of accelerating innovation for children and adolescents with cancer.

The purpose of the ACCELERATE platform is to provide a transparent forum for patients and parents organisations, academic paediatric oncologists and haematologists, pharmaceutical companies and EU regulatory network representatives to discuss, explain and seek ways to address specific overarching issues in promoting to timely improve the outcome of children and adolescents with cancer through the development of innovative anticancer medicines in a timely fashion.

Read more about the ACCELERATE platform on the website:

CDDF_logo     ITCC LOGO  SIOPE full logo


Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70